mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
0.0003 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0006 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.0006 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0007 |